nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00151	0.00869	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00147	0.00844	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00147	0.00844	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00145	0.00838	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00144	0.00831	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00143	0.00821	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL22—atopic dermatitis	0.0014	0.00804	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL22—atopic dermatitis	0.0014	0.00804	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CCL11—atopic dermatitis	0.00133	0.00767	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.0013	0.00747	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—NPS—atopic dermatitis	0.0013	0.00747	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00127	0.00732	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00127	0.00732	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00125	0.00718	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL27—atopic dermatitis	0.00124	0.00717	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL27—atopic dermatitis	0.00124	0.00717	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00118	0.0068	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00118	0.0068	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00116	0.00668	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00116	0.00668	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00112	0.00647	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00112	0.00647	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL17—atopic dermatitis	0.00112	0.00643	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL17—atopic dermatitis	0.00112	0.00643	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00109	0.00628	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CCR3—atopic dermatitis	0.00109	0.00625	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL22—atopic dermatitis	0.00106	0.00611	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CCL27—atopic dermatitis	0.00104	0.006	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00101	0.0058	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00101	0.0058	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.001	0.00576	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000983	0.00566	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000983	0.00566	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—NPS—atopic dermatitis	0.000968	0.00557	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—TAC1—atopic dermatitis	0.000968	0.00557	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000963	0.00555	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000963	0.00555	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000956	0.0055	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CXCR3—atopic dermatitis	0.000949	0.00547	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL27—atopic dermatitis	0.000946	0.00545	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000912	0.00525	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL11—atopic dermatitis	0.0009	0.00518	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL11—atopic dermatitis	0.0009	0.00518	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—KIF3A—atopic dermatitis	0.00089	0.00512	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000867	0.00499	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000859	0.00494	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000859	0.00494	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000859	0.00494	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000859	0.00494	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL17—atopic dermatitis	0.000848	0.00488	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000842	0.00485	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000842	0.00485	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000781	0.0045	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000767	0.00442	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCR3—atopic dermatitis	0.000734	0.00422	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCR3—atopic dermatitis	0.000734	0.00422	CbGpPWpGaD
Alprostadil—Lethargy—Prednisone—atopic dermatitis	0.000722	0.000874	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.00072	0.000871	CcSEcCtD
Alprostadil—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000719	0.00087	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—SELE—atopic dermatitis	0.000717	0.00413	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL22—atopic dermatitis	0.000717	0.00413	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL22—atopic dermatitis	0.000717	0.00413	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000703	0.00405	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000703	0.00405	CbGpPWpGaD
Alprostadil—Hypotension—Tacrolimus—atopic dermatitis	0.0007	0.000848	CcSEcCtD
Alprostadil—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000698	0.000844	CcSEcCtD
Alprostadil—Rash—Loratadine—atopic dermatitis	0.000692	0.000837	CcSEcCtD
Alprostadil—Dermatitis—Loratadine—atopic dermatitis	0.000691	0.000836	CcSEcCtD
Alprostadil—Headache—Loratadine—atopic dermatitis	0.000687	0.000832	CcSEcCtD
Alprostadil—Bradycardia—Prednisolone—atopic dermatitis	0.000686	0.00083	CcSEcCtD
Alprostadil—Sweating increased—Betamethasone—atopic dermatitis	0.000684	0.000828	CcSEcCtD
Alprostadil—Sweating increased—Dexamethasone—atopic dermatitis	0.000684	0.000828	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CCL11—atopic dermatitis	0.000684	0.00394	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000681	0.00392	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000681	0.00392	CbGpPWpGaD
Alprostadil—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.00068	0.000823	CcSEcCtD
Alprostadil—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000679	0.000822	CcSEcCtD
Alprostadil—Haemoglobin—Prednisolone—atopic dermatitis	0.000677	0.00082	CcSEcCtD
Alprostadil—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000677	0.000819	CcSEcCtD
Alprostadil—Asthenia—Mometasone—atopic dermatitis	0.000676	0.000818	CcSEcCtD
Alprostadil—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000675	0.000817	CcSEcCtD
Alprostadil—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000675	0.000817	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—FCER2—atopic dermatitis	0.000674	0.00388	CbGpPWpGaD
Alprostadil—Haemorrhage—Prednisolone—atopic dermatitis	0.000674	0.000815	CcSEcCtD
Alprostadil—Cardiac arrest—Prednisone—atopic dermatitis	0.000673	0.000814	CcSEcCtD
Alprostadil—Bradycardia—Hydrocortisone—atopic dermatitis	0.00067	0.000811	CcSEcCtD
Alprostadil—Pruritus—Mometasone—atopic dermatitis	0.000666	0.000806	CcSEcCtD
Alprostadil—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000661	0.0008	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CCL5—atopic dermatitis	0.000661	0.0038	CbGpPWpGaD
Alprostadil—Dyspepsia—Tacrolimus—atopic dermatitis	0.00066	0.000798	CcSEcCtD
Alprostadil—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000658	0.000796	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—NPS—atopic dermatitis	0.000654	0.00377	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—TAC1—atopic dermatitis	0.000654	0.00377	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—TAC1—atopic dermatitis	0.000654	0.00377	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—NPS—atopic dermatitis	0.000654	0.00377	CbGpPWpGaD
Alprostadil—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000652	0.000789	CcSEcCtD
Alprostadil—Nausea—Loratadine—atopic dermatitis	0.000652	0.000789	CcSEcCtD
Alprostadil—Visual impairment—Prednisolone—atopic dermatitis	0.000649	0.000786	CcSEcCtD
Alprostadil—Diarrhoea—Mometasone—atopic dermatitis	0.000644	0.00078	CcSEcCtD
Alprostadil—Hypokalaemia—Prednisone—atopic dermatitis	0.000644	0.00078	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000641	0.00369	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CXCR3—atopic dermatitis	0.000641	0.00369	CbGpPWpGaD
Alprostadil—Pain—Tacrolimus—atopic dermatitis	0.000641	0.000776	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—CCL27—atopic dermatitis	0.000639	0.00368	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL27—atopic dermatitis	0.000639	0.00368	CbGpPWpGaD
Alprostadil—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000634	0.000767	CcSEcCtD
Alprostadil—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000634	0.000767	CcSEcCtD
Alprostadil—Bradycardia—Triamcinolone—atopic dermatitis	0.000631	0.000763	CcSEcCtD
Alprostadil—Bradycardia—Methylprednisolone—atopic dermatitis	0.000629	0.000762	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000629	0.00362	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL22—atopic dermatitis	0.000627	0.00361	CbGpPWpGaD
Alprostadil—Haemoglobin—Triamcinolone—atopic dermatitis	0.000623	0.000754	CcSEcCtD
Alprostadil—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000622	0.000752	CcSEcCtD
Alprostadil—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000621	0.000752	CcSEcCtD
Alprostadil—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000621	0.000752	CcSEcCtD
Alprostadil—Rhinitis—Triamcinolone—atopic dermatitis	0.000621	0.000752	CcSEcCtD
Alprostadil—Rhinitis—Methylprednisolone—atopic dermatitis	0.00062	0.00075	CcSEcCtD
Alprostadil—Haemorrhage—Triamcinolone—atopic dermatitis	0.00062	0.00075	CcSEcCtD
Alprostadil—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000618	0.000748	CcSEcCtD
Alprostadil—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000618	0.000748	CcSEcCtD
Alprostadil—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000618	0.000747	CcSEcCtD
Alprostadil—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000617	0.000747	CcSEcCtD
Alprostadil—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000617	0.000747	CcSEcCtD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000616	0.00355	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000616	0.00355	CbGpPWpGaD
Alprostadil—Pharyngitis—Triamcinolone—atopic dermatitis	0.000615	0.000744	CcSEcCtD
Alprostadil—Myocardial infarction—Betamethasone—atopic dermatitis	0.000614	0.000743	CcSEcCtD
Alprostadil—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000614	0.000743	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000614	0.00353	CbGpPWpGaD
Alprostadil—Sweating increased—Prednisone—atopic dermatitis	0.000596	0.000721	CcSEcCtD
Alprostadil—Visual impairment—Methylprednisolone—atopic dermatitis	0.000596	0.000721	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CCR5—atopic dermatitis	0.000595	0.00343	CbGpPWpGaD
Alprostadil—Rash—Mometasone—atopic dermatitis	0.000594	0.000719	CcSEcCtD
Alprostadil—Dermatitis—Mometasone—atopic dermatitis	0.000593	0.000718	CcSEcCtD
Alprostadil—Body temperature increased—Tacrolimus—atopic dermatitis	0.000592	0.000717	CcSEcCtD
Alprostadil—Abdominal pain—Tacrolimus—atopic dermatitis	0.000592	0.000717	CcSEcCtD
Alprostadil—Headache—Mometasone—atopic dermatitis	0.00059	0.000714	CcSEcCtD
Alprostadil—Erythema—Prednisolone—atopic dermatitis	0.000587	0.00071	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000586	0.00337	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000586	0.00337	CbGpPWpGaD
Alprostadil—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000586	0.000709	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—CCL17—atopic dermatitis	0.000573	0.0033	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL17—atopic dermatitis	0.000573	0.0033	CbGpPWpGaD
Alprostadil—Erythema—Hydrocortisone—atopic dermatitis	0.000573	0.000693	CcSEcCtD
Alprostadil—Bradycardia—Dexamethasone—atopic dermatitis	0.000572	0.000693	CcSEcCtD
Alprostadil—Bradycardia—Betamethasone—atopic dermatitis	0.000572	0.000693	CcSEcCtD
Alprostadil—Haemoglobin—Betamethasone—atopic dermatitis	0.000565	0.000684	CcSEcCtD
Alprostadil—Haemoglobin—Dexamethasone—atopic dermatitis	0.000565	0.000684	CcSEcCtD
Alprostadil—Haemorrhage—Betamethasone—atopic dermatitis	0.000562	0.00068	CcSEcCtD
Alprostadil—Haemorrhage—Dexamethasone—atopic dermatitis	0.000562	0.00068	CcSEcCtD
Alprostadil—Nausea—Mometasone—atopic dermatitis	0.000559	0.000677	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CCL27—atopic dermatitis	0.000559	0.00322	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCR3—atopic dermatitis	0.000557	0.00321	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000554	0.00319	CbGpPWpGaD
Alprostadil—Hyperglycaemia—Prednisone—atopic dermatitis	0.000552	0.000668	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000547	0.00315	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—NPS—atopic dermatitis	0.000547	0.00315	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IL5—atopic dermatitis	0.000544	0.00313	CbGpPWpGaD
Alprostadil—Visual impairment—Dexamethasone—atopic dermatitis	0.000542	0.000656	CcSEcCtD
Alprostadil—Visual impairment—Betamethasone—atopic dermatitis	0.000542	0.000656	CcSEcCtD
Alprostadil—Erythema—Triamcinolone—atopic dermatitis	0.000539	0.000653	CcSEcCtD
Alprostadil—Erythema—Methylprednisolone—atopic dermatitis	0.000538	0.000651	CcSEcCtD
Alprostadil—Asthenia—Tacrolimus—atopic dermatitis	0.000538	0.000651	CcSEcCtD
Alprostadil—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000538	0.000651	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000536	0.00309	CbGpPWpGaD
Alprostadil—Myocardial infarction—Prednisone—atopic dermatitis	0.000535	0.000647	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—KIF3A—atopic dermatitis	0.00053	0.00305	CbGpPWpGaD
Alprostadil—Pruritus—Tacrolimus—atopic dermatitis	0.00053	0.000642	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00053	0.00305	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000528	0.00304	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000528	0.00304	CbGpPWpGaD
Alprostadil—Syncope—Prednisolone—atopic dermatitis	0.000526	0.000637	CcSEcCtD
Alprostadil—Back pain—Triamcinolone—atopic dermatitis	0.000522	0.000631	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000518	0.00298	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000518	0.00298	CbGpPWpGaD
Alprostadil—Loss of consciousness—Prednisolone—atopic dermatitis	0.000516	0.000624	CcSEcCtD
Alprostadil—Syncope—Hydrocortisone—atopic dermatitis	0.000514	0.000622	CcSEcCtD
Alprostadil—Diarrhoea—Tacrolimus—atopic dermatitis	0.000513	0.000621	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—IL5—atopic dermatitis	0.000509	0.00293	CbGpPWpGaD
Alprostadil—Convulsion—Prednisolone—atopic dermatitis	0.000508	0.000615	CcSEcCtD
Alprostadil—Hypertension—Prednisolone—atopic dermatitis	0.000506	0.000613	CcSEcCtD
Alprostadil—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000504	0.000609	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CCL17—atopic dermatitis	0.000501	0.00289	CbGpPWpGaD
Alprostadil—Bradycardia—Prednisone—atopic dermatitis	0.000498	0.000603	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—NPS—atopic dermatitis	0.000497	0.00286	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TAC1—atopic dermatitis	0.000497	0.00286	CbGpPWpGaD
Alprostadil—Convulsion—Hydrocortisone—atopic dermatitis	0.000496	0.000601	CcSEcCtD
Alprostadil—Dizziness—Tacrolimus—atopic dermatitis	0.000496	0.0006	CcSEcCtD
Alprostadil—Hypertension—Hydrocortisone—atopic dermatitis	0.000495	0.000599	CcSEcCtD
Alprostadil—Discomfort—Prednisolone—atopic dermatitis	0.000493	0.000597	CcSEcCtD
Alprostadil—Haemoglobin—Prednisone—atopic dermatitis	0.000492	0.000596	CcSEcCtD
Alprostadil—Haemorrhage—Prednisone—atopic dermatitis	0.00049	0.000593	CcSEcCtD
Alprostadil—Erythema—Betamethasone—atopic dermatitis	0.000489	0.000592	CcSEcCtD
Alprostadil—Erythema—Dexamethasone—atopic dermatitis	0.000489	0.000592	CcSEcCtD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000488	0.00281	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000487	0.00281	CbGpPWpGaD
Alprostadil—Syncope—Triamcinolone—atopic dermatitis	0.000484	0.000585	CcSEcCtD
Alprostadil—Syncope—Methylprednisolone—atopic dermatitis	0.000483	0.000584	CcSEcCtD
Alprostadil—Discomfort—Hydrocortisone—atopic dermatitis	0.000482	0.000583	CcSEcCtD
Alprostadil—Oedema—Prednisolone—atopic dermatitis	0.000479	0.000579	CcSEcCtD
Alprostadil—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000474	0.000574	CcSEcCtD
Alprostadil—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000473	0.000572	CcSEcCtD
Alprostadil—Rash—Tacrolimus—atopic dermatitis	0.000473	0.000572	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000472	0.00272	CbGpPWpGaD
Alprostadil—Dermatitis—Tacrolimus—atopic dermatitis	0.000472	0.000571	CcSEcCtD
Alprostadil—Shock—Prednisolone—atopic dermatitis	0.000471	0.00057	CcSEcCtD
Alprostadil—Cough—Triamcinolone—atopic dermatitis	0.000471	0.00057	CcSEcCtD
Alprostadil—Headache—Tacrolimus—atopic dermatitis	0.00047	0.000568	CcSEcCtD
Alprostadil—Oedema—Hydrocortisone—atopic dermatitis	0.000468	0.000566	CcSEcCtD
Alprostadil—Convulsion—Triamcinolone—atopic dermatitis	0.000467	0.000566	CcSEcCtD
Alprostadil—Tachycardia—Prednisolone—atopic dermatitis	0.000467	0.000565	CcSEcCtD
Alprostadil—Convulsion—Methylprednisolone—atopic dermatitis	0.000466	0.000564	CcSEcCtD
Alprostadil—Hypertension—Triamcinolone—atopic dermatitis	0.000466	0.000564	CcSEcCtD
Alprostadil—Hypertension—Methylprednisolone—atopic dermatitis	0.000465	0.000562	CcSEcCtD
Alprostadil—Infection—Hydrocortisone—atopic dermatitis	0.000464	0.000562	CcSEcCtD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000463	0.00267	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000463	0.00056	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—CCL11—atopic dermatitis	0.000462	0.00266	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL11—atopic dermatitis	0.000462	0.00266	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL5—atopic dermatitis	0.000462	0.00266	CbGpPWpGaD
Alprostadil—Shock—Hydrocortisone—atopic dermatitis	0.00046	0.000557	CcSEcCtD
Alprostadil—Tachycardia—Hydrocortisone—atopic dermatitis	0.000456	0.000552	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—FCER2—atopic dermatitis	0.000455	0.00262	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FCER2—atopic dermatitis	0.000455	0.00262	CbGpPWpGaD
Alprostadil—Flushing—Prednisone—atopic dermatitis	0.000454	0.00055	CcSEcCtD
Alprostadil—Skin disorder—Hydrocortisone—atopic dermatitis	0.000454	0.00055	CcSEcCtD
Alprostadil—Discomfort—Triamcinolone—atopic dermatitis	0.000454	0.000549	CcSEcCtD
Alprostadil—Discomfort—Methylprednisolone—atopic dermatitis	0.000453	0.000548	CcSEcCtD
Alprostadil—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000452	0.000547	CcSEcCtD
Alprostadil—Dry mouth—Triamcinolone—atopic dermatitis	0.000449	0.000544	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—KIF3A—atopic dermatitis	0.000447	0.00257	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL5—atopic dermatitis	0.000446	0.00257	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL5—atopic dermatitis	0.000446	0.00257	CbGpPWpGaD
Alprostadil—Nausea—Tacrolimus—atopic dermatitis	0.000445	0.000539	CcSEcCtD
Alprostadil—ABCC5—Disease—GLB1—atopic dermatitis	0.000442	0.00255	CbGpPWpGaD
Alprostadil—Oedema—Triamcinolone—atopic dermatitis	0.00044	0.000533	CcSEcCtD
Alprostadil—Syncope—Dexamethasone—atopic dermatitis	0.000439	0.000531	CcSEcCtD
Alprostadil—Syncope—Betamethasone—atopic dermatitis	0.000439	0.000531	CcSEcCtD
Alprostadil—Infection—Triamcinolone—atopic dermatitis	0.000437	0.000529	CcSEcCtD
Alprostadil—Hypotension—Hydrocortisone—atopic dermatitis	0.000437	0.000529	CcSEcCtD
Alprostadil—Infection—Methylprednisolone—atopic dermatitis	0.000436	0.000528	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000434	0.0025	CbGpPWpGaD
Alprostadil—Shock—Triamcinolone—atopic dermatitis	0.000433	0.000524	CcSEcCtD
Alprostadil—Shock—Methylprednisolone—atopic dermatitis	0.000432	0.000523	CcSEcCtD
Alprostadil—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00043	0.000521	CcSEcCtD
Alprostadil—Loss of consciousness—Betamethasone—atopic dermatitis	0.00043	0.000521	CcSEcCtD
Alprostadil—Tachycardia—Triamcinolone—atopic dermatitis	0.00043	0.00052	CcSEcCtD
Alprostadil—Tachycardia—Methylprednisolone—atopic dermatitis	0.000429	0.000519	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—SELE—atopic dermatitis	0.000428	0.00246	CbGpPWpGaD
Alprostadil—Skin disorder—Methylprednisolone—atopic dermatitis	0.000427	0.000516	CcSEcCtD
Alprostadil—Erythema—Prednisone—atopic dermatitis	0.000426	0.000516	CcSEcCtD
Alprostadil—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000426	0.000515	CcSEcCtD
Alprostadil—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000425	0.000514	CcSEcCtD
Alprostadil—Convulsion—Dexamethasone—atopic dermatitis	0.000424	0.000513	CcSEcCtD
Alprostadil—Convulsion—Betamethasone—atopic dermatitis	0.000424	0.000513	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—CCL22—atopic dermatitis	0.000423	0.00244	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL22—atopic dermatitis	0.000423	0.00244	CbGpPWpGaD
Alprostadil—Hypertension—Dexamethasone—atopic dermatitis	0.000423	0.000511	CcSEcCtD
Alprostadil—Hypertension—Betamethasone—atopic dermatitis	0.000423	0.000511	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000415	0.00239	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000415	0.00239	CbGpPWpGaD
Alprostadil—Discomfort—Betamethasone—atopic dermatitis	0.000412	0.000498	CcSEcCtD
Alprostadil—Discomfort—Dexamethasone—atopic dermatitis	0.000412	0.000498	CcSEcCtD
Alprostadil—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000412	0.000498	CcSEcCtD
Alprostadil—Hypotension—Methylprednisolone—atopic dermatitis	0.00041	0.000497	CcSEcCtD
Alprostadil—Pain—Prednisolone—atopic dermatitis	0.000409	0.000495	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CMA1—atopic dermatitis	0.000404	0.00233	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL11—atopic dermatitis	0.000404	0.00233	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCR5—atopic dermatitis	0.000402	0.00231	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCR5—atopic dermatitis	0.000402	0.00231	CbGpPWpGaD
Alprostadil—Pain—Hydrocortisone—atopic dermatitis	0.0004	0.000484	CcSEcCtD
Alprostadil—Oedema—Dexamethasone—atopic dermatitis	0.000399	0.000483	CcSEcCtD
Alprostadil—Oedema—Betamethasone—atopic dermatitis	0.000399	0.000483	CcSEcCtD
Alprostadil—Infection—Dexamethasone—atopic dermatitis	0.000397	0.00048	CcSEcCtD
Alprostadil—Infection—Betamethasone—atopic dermatitis	0.000397	0.00048	CcSEcCtD
Alprostadil—Feeling abnormal—Prednisolone—atopic dermatitis	0.000394	0.000477	CcSEcCtD
Alprostadil—Anaemia—Prednisone—atopic dermatitis	0.000394	0.000477	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000394	0.00227	CbGpPWpGaD
Alprostadil—Shock—Dexamethasone—atopic dermatitis	0.000393	0.000476	CcSEcCtD
Alprostadil—Shock—Betamethasone—atopic dermatitis	0.000393	0.000476	CcSEcCtD
Alprostadil—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000391	0.000473	CcSEcCtD
Alprostadil—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000391	0.000473	CcSEcCtD
Alprostadil—Tachycardia—Betamethasone—atopic dermatitis	0.00039	0.000472	CcSEcCtD
Alprostadil—Tachycardia—Dexamethasone—atopic dermatitis	0.00039	0.000472	CcSEcCtD
Alprostadil—Dyspepsia—Triamcinolone—atopic dermatitis	0.000388	0.000469	CcSEcCtD
Alprostadil—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000387	0.000468	CcSEcCtD
Alprostadil—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000386	0.000467	CcSEcCtD
Alprostadil—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000386	0.000467	CcSEcCtD
Alprostadil—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000385	0.000466	CcSEcCtD
Alprostadil—Syncope—Prednisone—atopic dermatitis	0.000382	0.000463	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—STAT6—atopic dermatitis	0.00038	0.00219	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL27—atopic dermatitis	0.000377	0.00217	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL27—atopic dermatitis	0.000377	0.00217	CbGpPWpGaD
Alprostadil—Pain—Triamcinolone—atopic dermatitis	0.000376	0.000456	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—CCR3—atopic dermatitis	0.000376	0.00217	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR3—atopic dermatitis	0.000376	0.00217	CbGpPWpGaD
Alprostadil—Loss of consciousness—Prednisone—atopic dermatitis	0.000375	0.000453	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000373	0.00215	CbGpPWpGaD
Alprostadil—Hypotension—Dexamethasone—atopic dermatitis	0.000373	0.000452	CcSEcCtD
Alprostadil—Hypotension—Betamethasone—atopic dermatitis	0.000373	0.000452	CcSEcCtD
Alprostadil—ABCC5—Metabolism—GLB1—atopic dermatitis	0.00037	0.00213	CbGpPWpGaD
Alprostadil—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00037	0.000447	CcSEcCtD
Alprostadil—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00037	0.000447	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—NPS—atopic dermatitis	0.00037	0.00213	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00037	0.00213	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TAC1—atopic dermatitis	0.00037	0.00213	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—NPS—atopic dermatitis	0.00037	0.00213	CbGpPWpGaD
Alprostadil—Convulsion—Prednisone—atopic dermatitis	0.000369	0.000447	CcSEcCtD
Alprostadil—Hypertension—Prednisone—atopic dermatitis	0.000368	0.000445	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000367	0.00211	CbGpPWpGaD
Alprostadil—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000363	0.000439	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000362	0.00209	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000362	0.00209	CbGpPWpGaD
Alprostadil—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000362	0.000438	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CXCL8—atopic dermatitis	0.00036	0.00207	CbGpPWpGaD
Alprostadil—Discomfort—Prednisone—atopic dermatitis	0.000359	0.000434	CcSEcCtD
Alprostadil—ABCC5—Metabolism—ADSL—atopic dermatitis	0.000355	0.00204	CbGpPWpGaD
Alprostadil—Dyspepsia—Betamethasone—atopic dermatitis	0.000352	0.000426	CcSEcCtD
Alprostadil—Dyspepsia—Dexamethasone—atopic dermatitis	0.000352	0.000426	CcSEcCtD
Alprostadil—Body temperature increased—Triamcinolone—atopic dermatitis	0.000348	0.000421	CcSEcCtD
Alprostadil—Oedema—Prednisone—atopic dermatitis	0.000348	0.000421	CcSEcCtD
Alprostadil—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000347	0.00042	CcSEcCtD
Alprostadil—Infection—Prednisone—atopic dermatitis	0.000346	0.000418	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—IL5—atopic dermatitis	0.000344	0.00198	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL5—atopic dermatitis	0.000344	0.00198	CbGpPWpGaD
Alprostadil—Shock—Prednisone—atopic dermatitis	0.000342	0.000414	CcSEcCtD
Alprostadil—Pain—Betamethasone—atopic dermatitis	0.000342	0.000413	CcSEcCtD
Alprostadil—Pain—Dexamethasone—atopic dermatitis	0.000342	0.000413	CcSEcCtD
Alprostadil—Tachycardia—Prednisone—atopic dermatitis	0.00034	0.000411	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CCL5—atopic dermatitis	0.000339	0.00195	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL17—atopic dermatitis	0.000338	0.00195	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL17—atopic dermatitis	0.000338	0.00195	CbGpPWpGaD
Alprostadil—Skin disorder—Prednisone—atopic dermatitis	0.000338	0.000409	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisone—atopic dermatitis	0.000336	0.000407	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000336	0.00194	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—NPS—atopic dermatitis	0.000336	0.00193	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—NPS—atopic dermatitis	0.000336	0.00193	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TAC1—atopic dermatitis	0.000336	0.00193	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TAC1—atopic dermatitis	0.000336	0.00193	CbGpPWpGaD
Alprostadil—Asthenia—Hydrocortisone—atopic dermatitis	0.000335	0.000406	CcSEcCtD
Alprostadil—Pruritus—Hydrocortisone—atopic dermatitis	0.000331	0.0004	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CCR3—atopic dermatitis	0.000329	0.0019	CbGpPWpGaD
Alprostadil—Feeling abnormal—Betamethasone—atopic dermatitis	0.000329	0.000398	CcSEcCtD
Alprostadil—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000329	0.000398	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000329	0.00189	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000329	0.00189	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL5—atopic dermatitis	0.000324	0.00187	CbGpPWpGaD
Alprostadil—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00032	0.000387	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000319	0.00184	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000319	0.00184	CbGpPWpGaD
Alprostadil—Dizziness—Prednisolone—atopic dermatitis	0.000317	0.000383	CcSEcCtD
Alprostadil—Asthenia—Triamcinolone—atopic dermatitis	0.000316	0.000382	CcSEcCtD
Alprostadil—Abdominal pain—Dexamethasone—atopic dermatitis	0.000316	0.000382	CcSEcCtD
Alprostadil—Body temperature increased—Dexamethasone—atopic dermatitis	0.000316	0.000382	CcSEcCtD
Alprostadil—Body temperature increased—Betamethasone—atopic dermatitis	0.000316	0.000382	CcSEcCtD
Alprostadil—Abdominal pain—Betamethasone—atopic dermatitis	0.000316	0.000382	CcSEcCtD
Alprostadil—Asthenia—Methylprednisolone—atopic dermatitis	0.000315	0.000381	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—IL5—atopic dermatitis	0.000312	0.0018	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL5—atopic dermatitis	0.000312	0.0018	CbGpPWpGaD
Alprostadil—Pruritus—Triamcinolone—atopic dermatitis	0.000311	0.000377	CcSEcCtD
Alprostadil—Pruritus—Methylprednisolone—atopic dermatitis	0.000311	0.000376	CcSEcCtD
Alprostadil—Dizziness—Hydrocortisone—atopic dermatitis	0.000309	0.000374	CcSEcCtD
Alprostadil—Dyspepsia—Prednisone—atopic dermatitis	0.000306	0.000371	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CCR5—atopic dermatitis	0.000305	0.00176	CbGpPWpGaD
Alprostadil—Rash—Prednisolone—atopic dermatitis	0.000302	0.000365	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—KIF3A—atopic dermatitis	0.000302	0.00174	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KIF3A—atopic dermatitis	0.000302	0.00174	CbGpPWpGaD
Alprostadil—Dermatitis—Prednisolone—atopic dermatitis	0.000302	0.000365	CcSEcCtD
Alprostadil—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000301	0.000364	CcSEcCtD
Alprostadil—Headache—Prednisolone—atopic dermatitis	0.0003	0.000363	CcSEcCtD
Alprostadil—ABCC5—Disease—SLC11A1—atopic dermatitis	0.000296	0.00171	CbGpPWpGaD
Alprostadil—Rash—Hydrocortisone—atopic dermatitis	0.000295	0.000357	CcSEcCtD
Alprostadil—Dermatitis—Hydrocortisone—atopic dermatitis	0.000295	0.000356	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—NPS—atopic dermatitis	0.000293	0.00169	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TAC1—atopic dermatitis	0.000293	0.00169	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000293	0.00169	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000293	0.00169	CbGpPWpGaD
Alprostadil—Headache—Hydrocortisone—atopic dermatitis	0.000293	0.000354	CcSEcCtD
Alprostadil—Dizziness—Triamcinolone—atopic dermatitis	0.000291	0.000352	CcSEcCtD
Alprostadil—Dizziness—Methylprednisolone—atopic dermatitis	0.00029	0.000352	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CXCR3—atopic dermatitis	0.000288	0.00166	CbGpPWpGaD
Alprostadil—Feeling abnormal—Prednisone—atopic dermatitis	0.000287	0.000347	CcSEcCtD
Alprostadil—Asthenia—Dexamethasone—atopic dermatitis	0.000287	0.000347	CcSEcCtD
Alprostadil—Asthenia—Betamethasone—atopic dermatitis	0.000287	0.000347	CcSEcCtD
Alprostadil—Nausea—Prednisolone—atopic dermatitis	0.000284	0.000344	CcSEcCtD
Alprostadil—Pruritus—Betamethasone—atopic dermatitis	0.000283	0.000342	CcSEcCtD
Alprostadil—Pruritus—Dexamethasone—atopic dermatitis	0.000283	0.000342	CcSEcCtD
Alprostadil—Nausea—Hydrocortisone—atopic dermatitis	0.000278	0.000336	CcSEcCtD
Alprostadil—Rash—Triamcinolone—atopic dermatitis	0.000278	0.000336	CcSEcCtD
Alprostadil—Dermatitis—Triamcinolone—atopic dermatitis	0.000277	0.000336	CcSEcCtD
Alprostadil—Rash—Methylprednisolone—atopic dermatitis	0.000277	0.000335	CcSEcCtD
Alprostadil—Dermatitis—Methylprednisolone—atopic dermatitis	0.000277	0.000335	CcSEcCtD
Alprostadil—Headache—Triamcinolone—atopic dermatitis	0.000276	0.000334	CcSEcCtD
Alprostadil—Headache—Methylprednisolone—atopic dermatitis	0.000275	0.000333	CcSEcCtD
Alprostadil—Abdominal pain—Prednisone—atopic dermatitis	0.000275	0.000333	CcSEcCtD
Alprostadil—Body temperature increased—Prednisone—atopic dermatitis	0.000275	0.000333	CcSEcCtD
Alprostadil—Diarrhoea—Dexamethasone—atopic dermatitis	0.000273	0.000331	CcSEcCtD
Alprostadil—Diarrhoea—Betamethasone—atopic dermatitis	0.000273	0.000331	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—CCL11—atopic dermatitis	0.000273	0.00157	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL11—atopic dermatitis	0.000273	0.00157	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CMA1—atopic dermatitis	0.000273	0.00157	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CMA1—atopic dermatitis	0.000273	0.00157	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL5—atopic dermatitis	0.000273	0.00157	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000268	0.00155	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000266	0.00153	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000266	0.00153	CbGpPWpGaD
Alprostadil—Dizziness—Dexamethasone—atopic dermatitis	0.000264	0.00032	CcSEcCtD
Alprostadil—Dizziness—Betamethasone—atopic dermatitis	0.000264	0.00032	CcSEcCtD
Alprostadil—Nausea—Triamcinolone—atopic dermatitis	0.000261	0.000316	CcSEcCtD
Alprostadil—Nausea—Methylprednisolone—atopic dermatitis	0.000261	0.000316	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000257	0.00148	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT6—atopic dermatitis	0.000256	0.00148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT6—atopic dermatitis	0.000256	0.00148	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000252	0.00145	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000252	0.00145	CbGpPWpGaD
Alprostadil—Rash—Betamethasone—atopic dermatitis	0.000252	0.000305	CcSEcCtD
Alprostadil—Rash—Dexamethasone—atopic dermatitis	0.000252	0.000305	CcSEcCtD
Alprostadil—Dermatitis—Betamethasone—atopic dermatitis	0.000252	0.000305	CcSEcCtD
Alprostadil—Dermatitis—Dexamethasone—atopic dermatitis	0.000252	0.000305	CcSEcCtD
Alprostadil—Headache—Betamethasone—atopic dermatitis	0.00025	0.000303	CcSEcCtD
Alprostadil—Headache—Dexamethasone—atopic dermatitis	0.00025	0.000303	CcSEcCtD
Alprostadil—Asthenia—Prednisone—atopic dermatitis	0.00025	0.000302	CcSEcCtD
Alprostadil—Pruritus—Prednisone—atopic dermatitis	0.000246	0.000298	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000243	0.0014	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000243	0.0014	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000242	0.00139	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.00024	0.00138	CbGpPWpGaD
Alprostadil—Diarrhoea—Prednisone—atopic dermatitis	0.000238	0.000288	CcSEcCtD
Alprostadil—Nausea—Dexamethasone—atopic dermatitis	0.000237	0.000287	CcSEcCtD
Alprostadil—Nausea—Betamethasone—atopic dermatitis	0.000237	0.000287	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CXCL10—atopic dermatitis	0.000233	0.00134	CbGpPWpGaD
Alprostadil—Dizziness—Prednisone—atopic dermatitis	0.00023	0.000278	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—CCL5—atopic dermatitis	0.000229	0.00132	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL5—atopic dermatitis	0.000229	0.00132	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000227	0.00131	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000227	0.00131	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR3—atopic dermatitis	0.000222	0.00128	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR3—atopic dermatitis	0.000222	0.00128	CbGpPWpGaD
Alprostadil—Rash—Prednisone—atopic dermatitis	0.000219	0.000265	CcSEcCtD
Alprostadil—Dermatitis—Prednisone—atopic dermatitis	0.000219	0.000265	CcSEcCtD
Alprostadil—Headache—Prednisone—atopic dermatitis	0.000218	0.000264	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—IL2—atopic dermatitis	0.000208	0.0012	CbGpPWpGaD
Alprostadil—Nausea—Prednisone—atopic dermatitis	0.000207	0.00025	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—CCR5—atopic dermatitis	0.000206	0.00119	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR5—atopic dermatitis	0.000206	0.00119	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000203	0.00117	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL5—atopic dermatitis	0.0002	0.00115	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TAC1—atopic dermatitis	0.000198	0.00114	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TAC1—atopic dermatitis	0.000198	0.00114	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NPS—atopic dermatitis	0.000198	0.00114	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NPS—atopic dermatitis	0.000198	0.00114	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCR3—atopic dermatitis	0.000194	0.00112	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCR3—atopic dermatitis	0.000194	0.00112	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2—atopic dermatitis	0.000194	0.00112	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGF—atopic dermatitis	0.000185	0.00107	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000185	0.00106	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL5—atopic dermatitis	0.000184	0.00106	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL5—atopic dermatitis	0.000184	0.00106	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR5—atopic dermatitis	0.00018	0.00104	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000178	0.00102	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2—atopic dermatitis	0.000176	0.00102	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL10—atopic dermatitis	0.000157	0.000905	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL10—atopic dermatitis	0.000157	0.000905	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000153	0.000881	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—atopic dermatitis	0.00015	0.000862	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000137	0.000791	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000137	0.000791	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL5—atopic dermatitis	0.000135	0.000779	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL5—atopic dermatitis	0.000135	0.000779	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—atopic dermatitis	0.000131	0.000756	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—atopic dermatitis	0.000131	0.000756	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGF—atopic dermatitis	0.000125	0.000721	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGF—atopic dermatitis	0.000125	0.000721	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000125	0.000718	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000125	0.000718	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—atopic dermatitis	0.000124	0.000713	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—atopic dermatitis	0.000122	0.000702	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—atopic dermatitis	0.000122	0.000702	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARA—atopic dermatitis	0.00012	0.000692	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—atopic dermatitis	0.000119	0.000686	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—atopic dermatitis	0.000119	0.000686	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—atopic dermatitis	0.000109	0.000628	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—atopic dermatitis	0.000104	0.0006	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—atopic dermatitis	0.000104	0.000597	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000103	0.000595	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NFKBIA—atopic dermatitis	0.000103	0.000595	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK8—atopic dermatitis	9.59e-05	0.000552	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD4—atopic dermatitis	9.4e-05	0.000541	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—atopic dermatitis	7.37e-05	0.000424	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—atopic dermatitis	7.37e-05	0.000424	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—atopic dermatitis	7.04e-05	0.000405	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—atopic dermatitis	7.04e-05	0.000405	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—atopic dermatitis	7.01e-05	0.000403	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—atopic dermatitis	7.01e-05	0.000403	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK8—atopic dermatitis	6.48e-05	0.000373	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK8—atopic dermatitis	6.48e-05	0.000373	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—atopic dermatitis	6.13e-05	0.000353	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—atopic dermatitis	5.08e-05	0.000293	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—atopic dermatitis	4.14e-05	0.000238	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—atopic dermatitis	4.14e-05	0.000238	CbGpPWpGaD
